[Advances in research on the mechanisms of reactive oxygen species in platelet activation and thrombosis]. [PDF]
Zhonghua Xue Ye Xue Za ZhiShen RY, Xu KL, Qiao JL, Fu P.
europepmc +1 more source
A case of glycogen storage disease type Ⅰa with gout as the first manifestation. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023 Dan L, Song X, Yu H.
europepmc +1 more source
[Disrupting atherosclerotic plaque formation <i>via</i> the "<i>qi</i> meridian-blood channel": mechanism of <i>Jiangzhi Huaban</i> Decoction for regulating hepatic reverse cholesterol transport to improve atherosclerosis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoWang H +8 more
europepmc +1 more source
[Radiation-Induced Heart Disease: Current Status and Challenges]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2022 Yang HJ, Zhang Y, Peng O, Zou BW.
europepmc +1 more source
[Mitochondrial G12630A variation is associated with statin-induced myalgia in Chinese patients with coronary artery disease]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2020 Zhou X, Wang Z, Qin M, Zhong S.
europepmc +1 more source
[Single-Center Experience of Treating Chronic Limb-Threatening Ischemia of Lower Limbs Combined with Diabetes]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2022 Luo X +11 more
europepmc +1 more source
[Pharmacodynamics of Qingxin Jieyu Granules for treatment of atherosclerosis and its regulatory mechanism for lipid metabolism]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoZhang S +7 more
europepmc +1 more source
Chest pain caused by left coronary artery spasm in a patient with anomalous origin of right coronary artery. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2022 Cao Y, Luo X, Liu Q, Zhou S.
europepmc +1 more source
[Interventional studies on acute-on-chronic liver failure: challenges and opportunities]. [PDF]
Zhonghua Gan Zang Bing Za ZhiYu PF, Xu MM, Chen Y.
europepmc +1 more source
[EASL clinical practice guidelines: prevention and treatment of hemorrhage and thrombosis in liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2022 Luo BH, Han GH.
europepmc +1 more source